U.S. Energy Services Stock News

Wondering if AppLovin's current share price reflects its true worth, or if the market is mispricing the story. The stock recently closed at US$442.39, with returns of 5.7% over 30 days, a 28.5% decline year to date, and 40.9% over the last year, alongside a very large 3 year return. Recent coverage has focused on AppLovin's position within software and digital advertising, as investors reassess how its platform fits into the broader app monetization ecosystem. That context helps explain why...

For readers wondering whether Valero Energy at around US$239.86 still offers value or if the easy gains are gone, this article breaks down what the current price might really be telling you. Recent share price moves have been strong, with returns of 4.0% over 7 days, 19.5% over 30 days, 45.1% year to date, 87.8% over 1 year, 103.2% over 3 years, and 290.1% over 5 years. Recent news around Valero Energy has focused on broad sector attention, capital allocation themes, and how large refiners...

SWK Holdings (SWKH) closed out FY 2025 with fourth quarter revenue of US$6.6 million and a basic EPS loss of US$1.60, compared with revenue of US$9.2 million and basic EPS of US$0.48 in the same quarter a year earlier. The trailing twelve month EPS came in at a loss of US$0.21 on revenue of US$37.6 million. Over recent quarters, revenue has moved from US$9.2 million in Q4 2024 to US$12.2 million in Q1 2025, US$8.1 million in Q2 2025 and US$10.6 million in Q3 2025. Basic EPS shifted from...

In its latest quarter, First Interstate BancSystem reported earnings per share ahead of analyst expectations but revenue below forecasts, alongside improving net interest margin and lower non‑performing assets. The company also expanded its share repurchase authorization, signaling management’s confidence in its capital position and balance sheet resilience. Next, we’ll examine how the expanded share repurchase authorization may influence First Interstate BancSystem’s broader investment...

Janus Henderson Group (NYSE:JHG) is back on investor screens after a recent move in its share price, with the stock closing at $50.43. This has prompted a closer look at its recent return profile. See our latest analysis for Janus Henderson Group. The recent pullback, with a 1-day share price return of a 1.83% decline, comes after a steadier backdrop that includes a 90-day share price return of 6.28% and a 1-year total shareholder return of 39.00%. This suggests that momentum has been...

Wondering whether GeneDx Holdings at around US$69.84 is a bargain or already pricing in a lot of optimism? This article walks through what the numbers currently say about value. The stock has had a choppy run, with a 10.2% decline over the last 7 days, a 14.9% decline over the last 30 days, a 47.2% decline year to date, a very large 3 year return, and a 33.1% decline over the last year. These swings have kept GeneDx on the radar for investors watching for changing expectations and risk...

Event context and recent share performance Merit Medical Systems (MMSI) shares have come under pressure recently, with the stock showing a 2.4% decline over the past day, 4.6% over the past week, and deeper pullbacks over the past month and past 3 months. See our latest analysis for Merit Medical Systems. The recent pullback, including a 30 day share price return of 18.9% decline and a year to date share price return of 22.8% decline, sits alongside a 1 year total shareholder return of 34.4%...

AptarGroup's Unidose Powder Nasal Spray System is being used in ENA Respiratory's Phase II trial for INNA-051. The trial targets prevention of symptomatic viral respiratory infections through a non-vaccine nasal approach. This use case highlights AptarGroup's role in advanced nasal drug delivery technologies within clinical pipelines. AptarGroup (NYSE:ATR) is widely known for drug delivery and consumer dispensing solutions, and this latest trial involvement puts its nasal systems in the...

MDU Resources Group (MDU) has drawn attention after recent trading, with the share price around $19.65 and mixed short term returns, including a 3.7% one day decline and 6.9% drop over the past week. See our latest analysis for MDU Resources Group. That recent 1-day share price return of negative 3.7% and 7-day return of negative 6.9% sit against a much stronger backdrop, with 1-year total shareholder return of 20.8% and 3-year total shareholder return of 93.6%. This suggests long term...

Hadrian and the U.S. Navy have agreed to work together to increase production of submarine parts. The partnership is aimed at supporting U.S. naval shipbuilding capacity and easing supply chain constraints. The move has potential implications for major submarine contractors, including General Dynamics (NYSE:GD). For investors watching General Dynamics at a current share price of $345.78, this new U.S. Navy and Hadrian partnership sits directly in the orbit of the company’s core submarine...

PitchBook, a Morningstar subsidiary, was named one of G2's top-rated financial services software products for 2026, reflecting customer driven ratings. Morningstar (NasdaqGS:MORN) announced the winners of its UK Awards for Investing Excellence, recognising firms and funds for investment research and stewardship in the UK market. For you as an investor, these updates highlight different sides of Morningstar’s business, from software and data through PitchBook to research and ratings under...

Opera (NasdaqGS:OPRA) and Celo have agreed a restructured, multi year partnership that makes Opera a major network stakeholder in the Celo ecosystem. The deal centers on MiniPay and a planned push to drive global stablecoin usage across up to 50 million Opera users. The partnership includes a 160 million CELO allocation, expansion of MiniPay into new markets, and grassroots roadshows to support user adoption. Opera, trading at $14.36, now ties a bigger part of its fintech plans to the Celo...

Wondering if Hess Midstream at around US$39.59 is still offering value, or if most of the easy gains are already on the table. The stock has returned 1.5% over the last 7 days, 4.5% over the last 30 days, 14.3% year to date and 0.4% over the past year, with very large returns over the past 3 and 5 years of 85.1% and 173.4% respectively. Recent coverage has focused on Hess Midstream's role as a midstream infrastructure provider and how that positions the company within the broader energy...

Wondering if Innospec, at around its recent US$65.89 close, is offering value or a value trap? This review breaks down what the current share price really reflects. The stock has recently seen a 4% decline over the past week, an 18.9% decline over the past month, and a 29.9% decline over the last year, which may signal that the market is reassessing both growth potential and risk. Recent coverage of Innospec has focused on its position within the chemicals sector and how investors are...

Welltower (NYSE:WELL) closed and upsized a US$6.25b revolving credit facility, securing revised terms. The facility adjustment extends the company’s debt maturity profile and provides additional funding flexibility. Moody's revised its credit rating outlook on Welltower to positive from stable following this financing step. For investors following healthcare real estate, Welltower is an important player in senior housing and medical facilities, areas tied to long term demographic trends...

Albemarle completed a debt tender offer, increasing its repurchase cap from $500 million to $650 million after strong investor interest. The company also filed an omnibus shelf registration covering a range of potential securities for future capital raising. These moves highlight active balance sheet management and add flexibility for funding future initiatives. For investors watching NYSE:ALB, these capital moves sit alongside a share price of $156.7 and a 1 year return of 105.6%. Over 3...

HA Sustainable Infrastructure Capital recently reported quarterly results that beat analyst expectations on both revenue and earnings, and in February it issued US$600 million of 7.125% Green Junior Subordinated Notes due 2056 to refinance obligations and fund eligible green projects. The quarter also highlighted investor interest in the firm’s CarbonCount framework and its premium valuation, which together heighten scrutiny of how efficiently new capital is deployed into sustainable...

TransUnion (NYSE:TRU) has rolled out new machine learning capabilities within its Device Risk fraud prevention solution. The update targets recent surges in digital fraud and suspected account takeovers, aiming to improve detection accuracy and reduce manual review work for clients. The company is highlighting adaptive, consortium driven risk scoring as a way to respond to more complex fraud patterns in digital channels. TransUnion enters this product update phase with its shares at $70.55...

In March 2026, AEye, Inc. announced it had joined the ANAB-accredited NVIDIA Halos AI Systems Inspection Lab to collaborate on validating safety, cybersecurity, and system integration of its Apollo, STRATOS, and OPTIS lidar solutions with NVIDIA DRIVE platforms. On the same day, AEye reported fourth-quarter 2025 sales of US$97,000 and a net loss of US$7.34 million, with full-year 2025 sales of US$233,000 and a net loss of US$33.96 million, showing modest revenue progress alongside continued...

If you are wondering whether FormFactor's current share price lines up with its underlying worth, this article will walk you through what the numbers are actually saying. The stock recently closed at US$92.22, with returns of 2.6% over 7 days, a 2.5% decline over 30 days, 55.8% year to date and 196.4% over 1 year that may catch your eye. Recent coverage has focused on FormFactor as a semiconductor testing specialist, with investors watching how its technology and customer exposure position...

TG Therapeutics, ticker NasdaqCM:TGTX, announced a new five year, $750 million senior secured credit facility with Blue Owl Capital. The agreement is described as non dilutive, meaning it does not involve issuing new equity to raise capital. The facility includes repayment of prior debt and could expand to as much as $1b in total available financing. TG Therapeutics focuses on developing and commercializing therapies in the biopharmaceutical space, where access to sizeable, flexible capital...

Arthur J. Gallagher & Co. reported that director Sherry Barrat informed the company on March 6, 2026 of her decision to retire from the Board, effective May 12, 2026, after which the Board will shrink from ten to nine members. Her retirement, alongside recent analyst commentary, sharpens investor focus on how board composition and external views may shape oversight of the company’s ongoing growth plans and risk management priorities. We’ll now examine how RBC’s renewed positive coverage,...

Investors may be wondering whether Progress Software's current share price reflects its true value, or if the recent weakness is opening up an opportunity. The stock closed at US$31.29, with returns of an 8.8% decline over 7 days, a 22.4% decline over 30 days, a 23.8% decline year to date, and a 42.5% decline over 1 year. These moves may have shifted how the market views its risk and reward trade off. Recent headlines have focused on Progress Software's role as a software provider and how...

Sionna Therapeutics (SION) is back in focus for investors after recent trading left the shares with a return of about 166% over the past year, contrasting with weaker near term moves. See our latest analysis for Sionna Therapeutics. The share price is currently US$36.39, and short term share price returns over 1 and 3 months have been weak, yet the 1 year total shareholder return of about 166% points to strong earlier momentum that has recently cooled. If you are looking beyond a single...